memantine has been researched along with Emesis in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The primary objective was to assess the safety and tolerability of rivastigmine capsules 6-12 mg/day plus memantine (5-20 mg/day) as measured by the incidences of vomiting and nausea compared with those reported in the rivastigmine United States Prescribing Information (US PI)." | 3.76 | Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32). ( Bhatnagar, V; Brannan, S; Koumaras, B; Meng, X; Olin, JT; Reyes, P, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, BJ | 1 |
| Kwon, KY | 1 |
| Olin, JT | 1 |
| Bhatnagar, V | 1 |
| Reyes, P | 1 |
| Koumaras, B | 1 |
| Meng, X | 1 |
| Brannan, S | 1 |
| Gallini, A | 1 |
| Sommet, A | 1 |
| Salandini, AM | 1 |
| Veyssière, P | 1 |
| Montastruc, JL | 2 |
3 other studies available for memantine and Emesis
| Article | Year |
|---|---|
Elderly woman presenting with unusual propriospinal myoclonus triggered by drug-induced nausea and vomiting.
Topics: Aged, 80 and over; Alzheimer Disease; Bupropion; Dopamine Agents; Dopamine Uptake Inhibitors; Female | 2018 |
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
Topics: Activities of Daily Living; Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Antipa | 2010 |
Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Anorexia; Antiparkinson Agents; Cholinesterase Inhibi | 2007 |